Top

Published in:

01-09-2010

Short-Term and Long-Term Outcomes After Simultaneous Resection of Colorectal Malignancies and Synchronous Liver Metastases

Authors: Eduardo de Santibañes, Diego Fernandez, Carlos Vaccaro, Guillermo Ojea Quintana, Fernando Bonadeo, Juan Pekolj, Carlos Bonofiglio, Ernesto Molmenti

Published in: World Journal of Surgery | Issue 9/2010

Abstract

Background

We evaluated the simultaneous resection of colorectal malignancies and synchronous liver metastases.

Methods

Between June 1982 and June 2006, a total of 752 patients underwent resection of colorectal hepatic metastases. In all, 185 (25%) of them underwent simultaneous resection of the hepatic lesions and the corresponding primary tumors.

Results

The median hospital stay was 8 days (range 4–24 days), with a median operating time of 4 h (range 2–8 h). Altogether, 62 (33.5%) patients required intraoperative transfusion of packed red blood cells (median 2.1 IU, range 1–5 IU), and 25 (13.5%) were given frozen fresh plasma (median 2.1 IU, range 1–4 IU). The morbidity rate was 20.5%. There were two postoperative deaths (mortality rate 1.08%) within 30 days of the surgical intervention. Major hepatectomy was associated with greater morbidity (37.2% vs. 16.2%, P < 0.01) and mortality (4.7% vs. 0%, P < 0.05) rates. For the overall survivals (OS) at 3 and 5 years were 60.1% (52.3–67.85%) and 36.1% (27.4-44.8%), respectively. Disease-free survivals (DFS) at 3 and 5 years were 37.7% (30.2–45.3%) and 26.5% (18.7–34.3%), respectively. Transfusion of blood products, CEA level ≥ 200 ng/dl, and N2 node status were found to be prognostic factors by univariate analysis. CEA level ≥ 200 ng/dl and N2 node status achieved prognostic significance by multivariate analysis.

Conclusions

The simultaneous resection of colorectal malignancies and synchronous liver metastases is safe, avoids an additional intervention, can be performed with low morbidity and mortality, and is associated with good oncologic outcomes. Node stage N2 and CEA level ≥ 200 ng/dl should be given special consideration when selecting patients.

Geoghegan JG, Scheele J (1999) Treatment of colorectal liver metastases. Br J Surg 86:158–169CrossRefPubMed

NHS Center for Reviews and Dissemination (1997) Effective health care: the management of colorectal cancer, vol 3, no. 6. University of York, York

NH Executive (1997) Guidance on commissioning cancer services: improving outcomes in colorectal cancer: the research evidence. Department of Health, London

Jemal A, Tiwari RC, Murray T (2004) Cancer statistics, 2004. CA Cancer J Clin 54:8–29CrossRefPubMed

Liu LX, Zhang WH, Jiang HC (2003) Current treatment for liver metastases from colorectal cancer. World J Gastroenterol 9:193–200PubMed

Saito H (2000) Screening for colorectal cancer. Dis Colon Rectum 43(Suppl):S78–S84CrossRefPubMed

Fong Y, Cohen AM, Fortner JG et al (1997) Liver resection for colorectal metastases. J Clin Oncol 15:938–946PubMed

Nadig DE, Wade TP, Fairchild RB et al (1997) Major hepatic resection: indication and results in a national hospital system from 1998 to 1992. Arch Surg 132:115–119PubMed

Nordlinger B, Jaeck D, Guiget (1992) Multicentric retrospective study by the French Surgical Association. In: Nordlinger B, Jaeck D et al (eds) Treatment of hepatic metastases of colorectal cancer. Springer-Verlag, Paris, pp 129–146

10.

Scheele J, Stangl R, Altendorf-Hofmann A et al (1991) Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 110:13–29PubMed

11.

Doci R, Gennari L, Bignami P et al (1991) One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognosis determinants. Br J Surg 78:797–801CrossRefPubMed

12.

Schlag P, Hohenberger P, Herfath C (1990) Resection of liver metastases in colorectal cancer: competitive analysis of treatment results in synchronous versus metachronous metastases. Eur J Surg Oncol 16:360–365PubMed

13.

Hughes KS, Simon R, Songhorabodi S et al (1988) Resection of the liver for colorectal metastases: a multi-institutional study of indication for resection. Surgery 103:278–288

14.

Nordlinger B, Guiguet M, Vaillant JC et al (1996) Surgical resection of colorectal carcinoma metastases to the liver: a prognostic scoring system to improve case selection, based on 1568 patients—Association Francaise de Chirurgie. Cancer 77:1254–1262CrossRefPubMed

15.

Elias D, Cavalcanti A, Sabourn JC et al (1998) Results of 136 curative hepatectomies with a safety margin of less than 10 mm for colorectal metastases. J Surg Oncol 69:88–93CrossRefPubMed

16.

Fong Y, Fortner J, Sun RL et al (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309–321CrossRefPubMed

17.

Minagawa M, Makuuki M, Torsilli G et al (2000) Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long term results. Ann Surg 231:487–499CrossRefPubMed

18.

Minagawa M, Yamamoto, Miwa S et al (2006) Selection criteria for simultaneous resection in patients with synchronous liver metastasis. Arch Surg 141:1006–1012CrossRefPubMed

19.

Lambert LA, Colacchio TA, Barth RJ (2000) Interval hepatic resection of colorectal metastases improves patient selection. Arch Surg 135:473–480CrossRefPubMed

20.

Martin R, Paty P, Fong Y et al (2003) Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastases. J Am Coll Surg 197:233–242CrossRefPubMed

21.

Lyass S, Zamir G, Matot I et al (2001) Combined colon and hepatic resection for synchronous colorectal liver metastases. J Surg Oncol 78:17–21CrossRefPubMed

22.

Vogt P, Raab R, Ringe B et al (1991) Resection of synchronous liver metastases from colorectal cancer. World J Surg 15:62–67CrossRefPubMed

23.

Weber JC, Bachellier P, Oussoultzoglou E et al (2003) Simultaneous resection of colorectal primary tumour and synchronous liver metastases. Br J Surg 90:956–962CrossRefPubMed

24.

Doko M, Zovak M, Ledinsky M et al (2000) Safety of simultaneous resections of colorectal cancer and liver metastases. Coll Antropol 24:381–390PubMed

25.

Tanaka K, Shimada H, Matsuo K et al (2004) Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases. Surgery 136:650–659CrossRefPubMed

26.

Fujita S, Akasu T, Moriya Y (2000) Resection of synchronous liver metastases from colorectal cancer. Jpn J Clin Oncol 30:7–11CrossRefPubMed

27.

De Santibañes E, Bonadeo F, Pekolj J et al (2002) Simultaneous colorectal and hepatic resection for colorectal cancer: post-operative and long-term outcomes. J Am Coll Surg 195:196–202CrossRefPubMed

28.

Chua HK, Sondenaa K, Tsiotos GG et al (2004) Concurrent vs. staged colectomy and hepatectomy for primary colorectal cancer with synchronous hepatic metastases. Dis Colon Rectum 47:1310–1316CrossRefPubMed

29.

Cady B, Stone MD (1991) The role of surgical resection of liver metastases in colorectal carcinoma. Semin Oncol 18:399–406PubMed

30.

Espi A, Arenas J, Garcia-Granero E et al (1996) Relationship of curative surgery on natural killer cell activity in colorectal cancer. Dis Colon Rectum 39:429–434CrossRefPubMed

31.

Topal B, Aerts JL, Roskams T et al (2005) Cancer cell dissemination during curative surgery for colorectal liver metastases. Eur J Surg Oncol 31:506–511CrossRefPubMed

32.

Raa ST, Oosterling SJ, van der Kaaij NP et al (2005) Surgery promotes implantation of disseminated tumor cells, but does not increase growth of tumor cell clusters. J Surg Oncol 92:124–129CrossRefPubMed

33.

Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMed

34.

Adam R (2007) Colorectal cancer with synchronous liver metastases. Br J Surg 94:129–131CrossRefPubMed

35.

Strasberg SM (1997) Terminology of liver anatomy and liver resections: coming to grips with hepatic Babel. J Am Coll Surg 184:413–434PubMed

36.

Moertel CG (1994) Chemotherapy for colorectal cancer. N Engl J Med 330:1136–1142CrossRefPubMed

37.

Douillard JY, Cunningham D, Roth AD et al (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355:1041–1047CrossRefPubMed

38.

Rougier P, Van Cutsem E, Bajetta E et al (1998) Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. Lancet 352:1407–1412CrossRefPubMed

39.

Rothenberg ML, Oza AM, Bigelow RH et al (2003) Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial. J Clin Oncol 21:2059–2069CrossRefPubMed

40.

De Gramont A, Figer A, Seymour M et al (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938–2947PubMed

41.

Giacchetti S, Perpoint B, Zidani R et al (2000) Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol 18:136–147PubMed

42.

Glove C, Douse P, Kane F et al (2002) Accuracy of investigations for asymptomatic colorectal liver metastases. Dis Colon Rectum 45:476–484CrossRef

43.

Hueber RH, Park KC, Sheph JF et al (2000) A meta-analysis of the literature for whole-body FDG PET. J Nucl Med 41:1177–1189

44.

Vall C, Andia E, Sanchez A et al (2001) Hepatic metastases from colorectal cancer: preoperative detection and assessment of respectability with helical CT. Radiology 218:55–60

45.

Kinkel K, Lu Y, Both M et al (2002) Detection of hepatic metastasis from cancer of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 224:748–756CrossRefPubMed

46.

Fong Y, Saldinger P, Akhurst T et al (1999) Utility of ¹⁸F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg 178:282–287CrossRefPubMed

47.

John TG, Garden OJ (1993) Needle tract seeding of primary and secondary liver carcinoma after percutaneous liver biopsy. HPB Surg 6:199–203CrossRefPubMed

48.

Fernandez FG, Drebin JA, Linehan DC et al (2004) Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 240:438–450CrossRefPubMed

49.

Hillingso JG, Wille-Jorgensen P (2009) Staged or simultaneous resection of synchronous liver metastases from colorectal cancer: a systematic review. Colorectal Dis 11:3–10CrossRefPubMed

50.

Jaeck D, Bachellier P, Weber JC et al (1996) Surgical treatment of synchronuos hepatic metastases of colorectal cancer: simultaneous or delayed resection. Ann Chir 50:507–512PubMed

51.

Foster JH, Berman MM (1997) Long-term survival; colon and rectum metastases. In: Solid liver tumor. Saunders, Philadelphia, pp 221–225

52.

Otchy D, Hyman NH, Simmang C et al (2004) Practice parameters for colon cancer. Dis Colon Rectum 47:1269–1284CrossRefPubMed

53.

Capussotti L, Ferrero A, Vigano L et al (2007) Major liver resections synchronous with colorectal surgery. Ann Surg Oncol 14:195–201CrossRefPubMed

54.

Capussotti L, Vigano L, Ferrero A et al (2007) Timing of resection of liver metastases synchronous to colorectal tumor: proposal for prognosis-based decisional model. Ann Surg Oncol 14:1143–1150CrossRefPubMed

55.

Elias D, Detroz B, Lasser P et al (1995) Is simultaneous hepatectomy and intestinal anastomosis safe? Am J Surg 169:254–260CrossRefPubMed

56.

Jenkins LT, Millikan KW, Bines SD et al (1997) Hepatic resection for metastatic colorectal cancer. Am Surg 63:605–610PubMed

57.

Iwatsuki S, Dvorchik I, Madariaga JR et al (1999) Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 189:291–299CrossRefPubMed

58.

Yamamoto J, Shimada K, Kosuge T et al (1999) Factors influencing survival of patients undergoing hepatectomy for colorectal metastases. Br J Surg 86:332–337CrossRefPubMed

59.

Yasui K, Hirai T, Kato T et al (1997) A new macroscopic classification predicts prognosis for patient with liver metastases from colorectal cancer. Ann Surg 226:582–586CrossRefPubMed

60.

Taylor M, Forster J, Langer B et al (1997) A study of prognostic factor for hepatic resection for colorectal metastases. Am J Surg 173:467–471CrossRefPubMed

61.

Ekberg H, Tranberg KG, Andersson R et al (1987) Pattern of recurrence in liver resection for colorectal secondaries. World J Surg 11:541CrossRefPubMed

62.

Scheele J, Stangl R, Altendorf-Hofmann A (1990) Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 77:1241–1246CrossRefPubMed

63.

Doci R, Bignami P, Gennari L (1996) Liver metastasis: clinico-pathological prognostic factors in metastasis from colorectal cancer. Ann Ital Chir 67:761–765PubMed

64.

Thelen A, Jonas S, Benckert C et al (2007) Simultaneous versus staged liver resection of synchronous liver metastases from colorectal cancer. Int J Colorectal Dis 22:1269–1276CrossRefPubMed

65.

Mentha G, Arnaud AD, Sylvain T et al (2008) ‘Liver first’ approach in the treatment of colorectal cancer with synchronous liver metastases. Dig Surg 25:430–435CrossRefPubMed

66.

Allen P, Kemeny N, Jarnagi W et al (2003) Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg 7:109–117CrossRefPubMed

67.

Mentha G, Majno PE, Andres A et al (2006) Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. Br J Surg 93:872–878CrossRefPubMed

68.

Benoist S, Nordlinger B (2007) Neoadjuvant treatment before resection of liver metastases. Eur J Surg Oncol 33(Suppl 2):535–541

69.

Nordlinger B, Sorbye H, Glimelius B et al (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371:1007–1016CrossRefPubMed

70.

Strasberg SM, Belghiti J, Clavien PA et al (2000) The Brisbane 2000 terminology of liver anatomy and resections. HPB (Oxford) 2:333–339

Title: Short-Term and Long-Term Outcomes After Simultaneous Resection of Colorectal Malignancies and Synchronous Liver Metastases
Authors: Eduardo de Santibañes
Diego Fernandez
Carlos Vaccaro
Guillermo Ojea Quintana
Fernando Bonadeo
Juan Pekolj
Carlos Bonofiglio
Ernesto Molmenti
Publication date: 01-09-2010
Publisher: Springer-Verlag
Published in: World Journal of Surgery / Issue 9/2010
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-010-0654-6

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Short-Term and Long-Term Outcomes After Simultaneous Resection of Colorectal Malignancies and Synchronous Liver Metastases

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 9/2010

Evolution of Type 2 Diabetes Mellitus in Non Morbid Obese Gastrectomized Patients with Roux en-Y Reconstruction: Retrospective Study

A New Surgical Trainer (BOPT) Improves Skill Transfer for Anastomotic Techniques in Gastrointestinal Surgery into the Operating Room: A Prospective Randomized Trial

Comparing Hepatic Resection and Transarterial Chemoembolization for Barcelona Clinic Liver Cancer (BCLC) Stage B Hepatocellular Carcinoma: Change for Treatment of Choice?

Experience of the Reliability of Intraoperative Sampling of Tissue PTH in Parathyroid Surgery: Reply

Predictive Value of Tumor Proliferative Indices in Periampullary Cancers: Ki-67, Mitotic Activity Index (MI) and Volume Corrected Mitotic Index (M/V) Using Tissue Microarrays

Outcomes of Robot-Assisted Pancreaticoduodenectomy in Patients Older Than 70 Years: A Comparative Study